Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
$27.60
+1.2%
$26.30
$22.05
$45.79
$3.51B2.751.04 million shs678,309 shs
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$129.86
+4.3%
$126.65
$55.25
$146.68
$12.27B0.951.28 million shs16.98 million shs
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
$135.22
+1.5%
$113.03
$51.04
$135.75
$13.21B2.091.15 million shs1.36 million shs
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$189.80
+2.1%
$172.95
$119.90
$189.95
$12.70B1.26614,007 shs847,368 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
0.00%+8.70%+10.40%-11.51%-26.36%
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
0.00%+5.18%-0.59%+0.92%+5.06%
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
-0.05%+3.12%+13.67%+43.41%+89.92%
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
-0.05%+7.61%+11.73%+10.92%+43.65%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
2.841 of 5 stars
3.40.00.00.03.30.83.1
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
4.7651 of 5 stars
4.41.00.04.23.12.51.9
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
3.9478 of 5 stars
2.53.00.04.32.62.51.3
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
4.8673 of 5 stars
2.23.01.74.62.53.33.8

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
2.86
Moderate Buy$42.8655.28% Upside
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
2.80
Moderate Buy$164.0026.29% Upside
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
3.06
Buy$120.41-10.95% Downside
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
2.40
Hold$190.430.33% Upside

Current Analyst Ratings

Latest THC, UHS, SGRY, and SRPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/31/2024
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$157.00
5/30/2024
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/30/2024
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$107.00 ➝ $140.00
5/30/2024
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$126.00 ➝ $150.00
5/30/2024
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$153.00
5/30/2024
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/30/2024
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$182.00 ➝ $186.00
5/30/2024
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$198.00
5/28/2024
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Sector Perform$157.00 ➝ $142.00
5/20/2024
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$166.00
5/20/2024
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$189.00 ➝ $226.00
(Data available from 6/2/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
$2.74B1.28$1.80 per share15.37$23.90 per share1.15
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$1.24B9.87N/AN/A$10.17 per share12.77
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
$20.55B0.64$16.21 per share8.34$50.60 per share2.67
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$14.28B0.89$19.47 per share9.75$94.22 per share2.01

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
-$11.90MN/A32.0925.092.180.02%3.65%1.61%8/6/2024 (Estimated)
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
-$535.98M$0.111,180.5515.82N/A1.20%2.20%0.58%8/7/2024 (Estimated)
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
$611M$25.775.2516.041.3912.53%26.76%3.27%7/29/2024 (Estimated)
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$717.79M$11.8016.0812.650.945.57%13.34%5.93%7/23/2024 (Estimated)

Latest THC, UHS, SGRY, and SRPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024Q1 2024
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
$0.04$0.06+$0.02$0.22$707.66 million$717.40 million
5/1/2024Q1 24
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
-$0.11$0.73+$0.84$0.39$375.52 million$413.50 million    
4/30/2024Q1 2024
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
$1.45$3.22+$1.77-$14.94$5.15 billion$5.37 billion    
4/24/2024Q1 2024
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$3.14$3.70+$0.56$3.58$3.78 billion$3.84 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
N/AN/AN/AN/AN/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
N/AN/AN/AN/AN/A
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
N/AN/AN/AN/AN/A
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$0.800.42%+58.74%6.78%N/A

Latest THC, UHS, SGRY, and SRPT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/15/2024
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
quarterly$0.200.44%6/3/20246/3/20246/17/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
0.92
1.71
1.56
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1.18
4.05
3.44
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
2.58
1.44
1.37
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
0.75
1.38
1.28

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
N/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
86.68%
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
95.44%
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
86.05%

Insider Ownership

CompanyInsider Ownership
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
2.30%
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7.70%
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
0.93%
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
16.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
13,500127.09 million124.17 millionOptionable
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1,31494.52 million87.25 millionOptionable
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
106,50097.68 million96.78 millionOptionable
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
96,70066.93 million56.15 millionOptionable

THC, UHS, SGRY, and SRPT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Surgery Partners logo

Surgery Partners

NASDAQ:SGRY
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Sarepta Therapeutics logo

Sarepta Therapeutics

NASDAQ:SRPT
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Tenet Healthcare logo

Tenet Healthcare

NYSE:THC
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Universal Health Services logo

Universal Health Services

NYSE:UHS
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. It also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.